{
    "code": "02023266",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023266",
    "time": "2020-02-25 13:05:34",
    "許可證字號": "衛署藥輸字第023266號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/08\/23",
    "發證日期": "90\/08\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202326606",
    "中文品名": "可普諾維膜衣錠　１５０毫克\/１２．５毫克",
    "英文品名": "COAPROVEL 150MG\/12.5MG FILM-COATED TABLETS",
    "適應症": "本態性高血壓。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1424601100  賽諾菲股份有限公司",
        "申請商地址": "台北市信義區松仁路3號7樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FFR0314000  Sanofi Clir",
            "製造廠廠址": "54 Avenue de la Boetie, 75008, Paris, France",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200038400",
            "成分名稱": "IRBESARTAN",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡紅橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "2775",
        "標記二": "賽諾菲聖德拉堡1"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02023266.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023266&Seq=436&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Coaprovel_LPI_C_CCDS v15_2019.04.29_TFDA comments-clean-108-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023266&Seq=004&Type=9"
        },
        {
            "title": "020232660003.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023266&Seq=003&Type=8"
        }
    ]
}